Our treatments available for multiple myeloma from newly diagnosed to relapse/refractory

$Card displaying CARVYKTI®, an advanced therapy for relapsed or refractory multiple myeloma, with a 'Discover More' button.$

CARVYKTI® (ciltacabtagene autoleucel) is developed and co-marketed with Legend Biotech.